Welcome to our dedicated page for Stratasys news (Ticker: SSYS), a resource for investors and traders seeking the latest updates and insights on Stratasys stock.
Stratasys Ltd. (NASDAQ: SSYS) is frequently in the news for developments in polymer-based 3D printing and additive manufacturing across aerospace, automotive, healthcare, and industrial markets. Its announcements highlight how smart, connected 3D printers, polymer materials, and a supporting software ecosystem are applied in real-world production and prototyping environments.
Recent news has showcased industrial and automotive applications, such as Subaru of America’s use of the Stratasys F770 printer with the T25 High Speed Head to cut tooling development time and reduce prototyping costs. In aerospace, Stratasys reports that Airbus produces certified flight-ready parts using ULTEM 9085 filament CG on industrial FDM printers, with thousands of parts already in service on aircraft models including the A320, A350, and A400M.
Healthcare-focused stories emphasize Digital Anatomy technology and specialized materials. Stratasys has announced full U.S. availability of its RadioMatrix radiopaque material, enabling CT and X-ray-visible models for imaging research, training, and device testing. Other coverage describes Digital Anatomy-based eye models for eyelid surgery training in Europe, supporting lifelike, repeatable surgical education.
Stratasys news also covers software and ecosystem partnerships, such as the integration of Novineer’s NoviPath performance simulation with GrabCAD Print Pro, and its collaboration with Tritone Technologies to add metal and ceramic capabilities. Additional updates include participation in defense exercises like Trident Warrior 25, where distributed manufacturing with Stratasys printers and Stratasys Direct on-demand production supported U.S. Navy operations.
On this SSYS news page, readers can follow earnings releases, product and material launches, strategic collaborations, and sector-specific case studies that illustrate how Stratasys technologies are used in production and training. Investors, engineers, and industry professionals can use this feed to monitor ongoing developments in Stratasys’ additive manufacturing activities.
Stratasys Ltd. (SSYS) reported a Q4 2021 revenue of $167 million, marking a 17.3% increase year-over-year. However, the company experienced a GAAP net loss of $4.8 million or $0.07 per diluted share. Non-GAAP net income stood at $0.5 million, reflecting a decline from previous figures. The company generated $4.4 million in cash from operations, ending the year with $502.2 million in cash and no debt. Looking ahead, Stratasys expects 2022 revenue between $680 million and $695 million with growth anticipated in the second half.
Stratasys (NASDAQ: SSYS) has collaborated with Radford to produce over 500 3D-printed parts for the Lotus Type 62-2 supercar, featured in the Discovery+ show Radford Returns. This partnership showcases the integration of advanced 3D printing technologies, such as FDM and PolyJet, in automotive manufacturing. The project exemplifies the shift towards customized manufacturing, allowing for unique vehicle designs with efficiency. The use of various Stratasys printers enabled Radford to achieve design freedom and meet the expectations of luxury vehicle aesthetics.
Summary not available.
Stratasys announced a sponsorship for the
Stratasys emphasizes the importance of community support and aims to foster innovation in healthcare.
Stratasys Ltd (NASDAQ: SSYS) will announce its financial results for Q4 and full year 2021 on February 23, 2022 at 8:30 a.m. ET. A conference call will follow to discuss these results. Investors can access the call via a live webcast on the company’s investor relations website or by telephone at 877-407-0619 (U.S.) and +1-412-902-1012 (international). Stratasys is at the forefront of additive manufacturing, providing innovative 3D printing solutions across various industries including aerospace and healthcare, enhancing design and manufacturing agility.
MakerBot, a Stratasys company (NASDAQ: SSYS), is expanding its 3D printing materials with three new LUVOCOM® 3F products from LEHVOSS Group. This addition brings the total number of METHOD® materials to 30, enhancing options for engineering applications. The new materials feature high strength and heat resistance, suitable for prototyping and end-use parts. Notably, they provide enhanced performance characteristics, such as reduced warpage and excellent surface finish, improving the overall 3D printing experience.
Stratasys (NASDAQ: SSYS) will participate in the 24th Annual Needham Growth Conference from January 10–14, 2022. A fireside chat featuring CEO Dr. Yoav Zeif and incoming CFO Eitan Zamir will take place on January 13, 2022, at 12:30 p.m. ET. The event will be broadcast live and archived for 180 days, accessible at this link. Stratasys is recognized for its innovative 3D printing solutions across various industries, enhancing product design and manufacturing efficiency.
Stratasys Ltd. (NASDAQ: SSYS) announced the promotion of Eitan Zamir to chief financial officer, effective February 2022. Zamir, previously the vice president of finance, succeeds Lilach Payorski, who served nine years in the role. Zamir has proven financial expertise and has been integral in financial operations, reporting, and capital raising since joining Stratasys in 2019. CEO Dr. Yoav Zeif praised Zamir's leadership qualities, underscoring his alignment with the company’s growth strategy.
Stratasys has unveiled the Origin One Dental 3D printer, enhancing its offerings in the dental sector. This printer is designed for high accuracy and efficiency, capitalizing on the growing demand in the dental market, which is projected to reach $6.5 billion by 2025. Built on proprietary P3™ technology, it offers an open material infrastructure for diverse applications. This launch aligns with Stratasys' acquisition of Origin and complements their existing J5 DentaJet printer, together aiming to address the needs of modern dental labs.
Stratasys has launched the Digital Anatomy Creator software to enhance its Digital Anatomy 3D Printers, allowing healthcare providers to create patient-specific anatomic models more effectively. This software offers advanced customization options, enabling users to replicate human tissues accurately for diagnostic purposes and surgical preparation. Additionally, Stratasys collaborates with Synopsys and Materialise to integrate FDA 510(k)-cleared workflows in medical modeling, which facilitates point-of-care 3D printing. Healthcare providers can use this technology to improve surgical outcomes and reduce operational costs.